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AggregationAs fundamental components in innate immunity, antimicrobial peptides (AMPs) hold great potentials in the
treatment of persistent infections involving slow-growing or dormant bacteria in which, selective inhibition of
prokaryotic bacteria in the context of eukaryotic cells is not only an essential requirement, but also a critical chal-
lenge in the development of antimicrobial peptides. To identify the sequence and structural properties critical for
antimicrobial activity, a series of peptides varying in sequence, length, hydrophobicity/charge ratio, and second-
ary structure, were designed and synthesized. Their antimicrobial activities were then tested using Escherichia
coli and HEK293 cells, together with several index activities against model membrane, including liposome leak-
age, fusion, and aggregation.While no evident correlation between the antimicrobial activity and the property of
the peptides was observed, common activities against model membrane were nevertheless identiﬁed for the
active antimicrobial peptides: mediating efﬁcient membrane leakage, negligible membrane fusion and liposome
aggregation. Therefore, in addition to identifying one highly active antimicrobial peptide, our study further sheds
light on the design principle for these molecules.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Antimicrobial peptides are abundant and diverse group ofmolecules
produced and distributed in a variety of invertebrate, plant, and animals
species, serving as “defender” against bacteria, fungi, viruses, and other
invasion conceivable substances [1]. Although their antibacterial activi-
ty was proposed to derive mainly from their membrane disruption ca-
pability, recent studies suggested that AMPs also inhibited the
formation of cell walls, as well as the synthesis of DNA, RNA and pro-
teins [2].
AMPs are peptides with a length less than 100 amino acids. Their
amino acid composition, amphiphilicity, cationic charge, and size
allow them to attach to and insert into the bilayer membrane of bacte-
ria, as well as to achieve selectivity between prokaryotic bacteria and
eukaryoticmammalian cells. To elucidate the relationship betweenpep-
tide structures and antibacterial activities, a variety of peptides differing
in size, hydrophobicity, charge density, as well as secondary structure
were studied [3–11]. Generally, higher hydrophobicity of AMPs led to
enhanced membrane disturbance and compromised cellular selectivity@pku.edu.cn (D. Liang).[12], while higher charge density led to enhanced electrostatic interac-
tion between peptides andmembrane, and lowered toxicity tomammal
cells [6,13]. In addition, secondary structure of AMPs also showed signif-
icant inﬂuence. Studies indicated that AMPs stayed random in water,
and formed α-helix upon interacting with membrane [7]. In response
to the environment stimulations, change of the peptide secondary
structure can cause more efﬁcient membrane leakage [14]. The effect
was more evident for less-charged membrane [9]. It was also found
that AMPs with increasing lengthweremore destructive tomembranes
[15]. Even though the effect of individual peptide property has been
well understood, combinational effects of multiple properties are rarely
investigated, which presents a critical challenge for the development of
high performance AMPs [11].
Technically, the performances of AMPs are usually characterized by
liposome leakage, using large unilamellar vesicles (LUVs) or giant
unilamellar vesicles (GUV) as themodelmembrane. The degree of leak-
age is taken as a criterion to evaluate themembrane destroying capabil-
ity of the AMPs [5,10,16]. The kinetics of the liposome leakage are also
used to measure the interactions between AMPs and membranes [17].
Despite these investigations, the liposome leakage is not directly related
to the antibacterial activity of AMPs. Particularly for LUVs, the leakages
are often found to be accompanied with liposome aggregation and
membrane fusion [18]. However, the underlying mechanisms and
their effects on the antibacterial activity of AMPs have not been deﬁned.
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terms of peptide sequence, length, hydrophobicity/charge ratio, and sec-
ondary structure (Table 1). To make the results comparable, only two
types of amino acids, lysine and leucinemainly, were used for each pep-
tide, with an exception of K14 consisting of only lysine. The peptides
were designed to be with a sequence of bola-typed (K3L8K3) or
surfactant-like (K6L8). Peptides with the sequence of (KL2KL2K)2 or
(KL2KL3)2 were designed to take an amphiphilic α-helical structure, ac-
cording to the helical wheel diagram prediction. To evaluate the inﬂu-
ence of the hydrophobicity and secondary structure, the leucine in
K3L8K3 was replaced by either isoleucine or valine, in peptide K3I8K3
and K3V8K3. To evaluate the inﬂuence of peptide length, repeated se-
quence was designed for peptide K6L16K6, compared to peptide K3L8K3.
Using LUVs composed of 1,2-dipalmitoyl-sn-glycero-3- phosphocholine
(DPPC) and 1,2-dipalmitoyl -sn -glycero-3-phospho-(1′-rac-glycerol)
(DPPG), the kinetics of membrane leakage, liposome aggregation, and
membrane fusion was comparatively investigated. Antibacterial activity
of the peptideswas investigatedwith E. coli, while their cytotoxicitywas
examined with HEK293 cells.2. Materials and methods
2.1. Materials
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, N99%),
TbCl3·6H2O, and 2,6-Pyridinedicarboxylic acid (DPA) were pur-
chased from Sigma. Chloroform solution of 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-
4-yl) (NBD-DPPE, ammonium salt), 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (Rh-DPPE,
ammonium salt), and 1,2-dipalmitoyl-sn-glycero-3-phospho-(1′-rac-
glycerol) (DPPG, sodium salt) were purchased from Avanti Polar Lipids,
Inc. All peptides (purity N98%) were synthesized by GL Biochem
(Shanghai, China) Ltd. Mueller–Hinton Broth was from Hope-Bio Tech-
nology co. Ltd. Fetal bovine serum was from HyClone Laboratories. Inc.
Penicillin and streptomycin were from Life Technologies, Gibco. Milli-
Q water (18.2 MΩ.cm) was used in all the experiments.2.2. Circular dichroism spectra
Peptides were individually dissolved in Milli-Q water and sonicated
for 5–10 s to obtain stock solution with a concentration of 1.00 or
0.25 mg/mL. Milli-Q water or triﬂuoroethanol (TFE) was used to dilute
the stock solution. The circular dichroism (CD) spectra were measured
from 190 to 250 nm at 50 °C using a JASCO J-810 spectrometer (AVIV,
USA), with a 1.0 cm path length cuvette. Temperature was controlled
by using a PolyScience programmable temperature controller. Peptides
inMilli-Qwater (25 μM) or 50% TFE (12.5 μM)was used in themeasure-
ment. For each peptide, three independent assays were performed.Table 1
The sequences and secondary structures of peptides in 50% TFE.
Name Sequence α-helix β-sheet β-turn random
(KL2KL3)2 Ac-KLLKLLLKLLKLLL-amide 0.58 0.03 0.11 0.27
(KL2KL2K)2 Ac-KLLKLLKKLLKLLK-amide 0.58 0.04 0.12 0.27
K3L8K3 Ac-KKKLLLLLLLLKKK-amide 0.62 0.06 0.12 0.22
K6L8 Ac-KKKKKKLLLLLLLL-amide 0.50 0.06 0.15 0.28
K3I8K3 Ac-KKKIIIIIIIIKKK-amide 0.35 0.17 0.20 0.30
K3V8K3 Ac-KKKVVVVVVVVKKK-amide 0.10 0.34 0.18 0.26
K6L16K6 Ac-KKKKKLLLLLLLL-
LLLLLLLLKKKKKK-amide
0.41 0.12 0.18 0.29
K14 Ac-KKKKKKKKKKKKKK-amide N/A N/A N/A N/A2.3. Preparation of LUVs
DPPC/DPPG LUVswere prepared using the Banghammethod [19]. In
brief, DPPC solution (chloroform) and DPPG solution (methanol, v/v =
9/1) were added into a 50mL pyriform ﬂask at a molar ratio of 1:1, and
mixed with Teﬂon beads. The organic solvent was removed at 50 °C
under reduced pressure, followed by vacuuming overnight. The lipo-
some ﬁlm was then hydrated with Hepes buffer (pH 7.40, 20 mM
Hepes, 150 mM NaCl, 0.1 mM EDTA) at 50 °C on a rotary evaporator
for 1 h, with occasional vortexing. Using a mini-extruder (Avanti Polar
Lipids, Inc.) and a polycarbonate ﬁlter with 100 nm pore size, liposome
solution was extruded at 50 °C for 21 times. DPPC/DPPG liposome la-
beled with ﬂuorescent probes (Rh-DPPE) was prepared similarly. The
ﬁnal concentration of liposome was determined by a modiﬁed Bartlett
method [20]. The stock solution of liposome was then diluted to
15.6 μM in Hepes buffer.
2.4. Liposome leakage assay
Liposome leakage assays were performed at 50 °C using ﬂuores-
cence TbCl3-DPA [21]. Tb/DPA-loaded liposome (10 mg/mL) was pre-
pared in a buffer (1.25 mM TbCl3, 25 mM Na-citrate, 25 mM DPA,
60mMNaCl, 20mMNa-Hepes, pH 7.4). The non-encapsulated reagents
were removed byﬁltrating the solution through a SephadexG-25Mcol-
umn (column size, 1.0 × 20 cm; elution buffer: 150 mM NaCl, 1 mM
EDTA, 20 mM Na-Hepes, pH 7.4). The ﬂuorescence intensity of the Tb/
DPA-loaded liposome was set as I∞. 100% leakage was obtained by
adding 0.05 wt.% Triton X-100 to the “Tb/DPA-loaded” liposome (total
lipid concentration 15.6 μM). Theﬂuorescence intensity at 100% leakage
was set as I0. Liposome leakage in the presence of peptidewasmeasured
with a Fluoromax-4 spectrophotoﬂuorimeter. The excitation and emis-
sion wavelengths were 280 and 543 nm, respectively. A cutoff ﬁlter at
430 nmwas placed in the emission path to eliminate the contributions
from the scattered light. In accordance with the molar ratio of 0.053
after adding the peptides, the ﬂuorescence intensity of the mixture
was denoted as It, and the percentage of liposome leakage was calculat-
ed according to the equation:
Leakage %ð Þ ¼ 100  I∞− Itð Þ= I∞− I0ð Þ ð1Þ
2.5. Laser light scattering
A commercialized spectrometer equipped with a BI-TurboCo
Digital Correlator (BI-200SM, Brookhaven Instruments Corporation,
Holtsville) was used to perform both static light scattering (SLS)
and dynamic light scattering (DLS), over a scattering angular range
of 20–120°. A vertically polarized, 100 mW solid-state laser (GXC-
III, CNI, Changchun, China) operating at 532 nm was used as the
light source.
In DLS, the intensity–intensity time correlation function G(2)(τ) in
the self-beating mode was obtained on the basis of
G 2ð Þ τð Þ ¼ A 1þ β g 1ð Þ τð Þ
 2
 
ð2Þ
where A is the measurement base line, β is a coherence factor, τ is the
delay time, and g(1)(τ) is the normalized ﬁrst-order electric ﬁeld time
correlation function. g(1)(τ) was relatedwith the linewidth distribution
G(Γ) by
g 1ð Þ τð Þ ¼
Z ∞
0
G Γð Þe−ΓτdΓ ð3Þ
By using a Laplace inversion program, CONTIN [22], the normalized
distribution function of the characteristic line width G(Γ) was obtained.
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was a function of both C and q, which was expressed as
Γ=q2 ¼ D 1þ kdCð Þ 1þ f Rgq
 2  ð4Þ
where kd, and f are the diffusion second virial coefﬁcient and a dimen-
sionless constant, respectively.
D was further converted into the hydrodynamic radius Rh by using
the Stokes–Einstein equation
D ¼ kBT=6πηRh ð5Þ
where kB, T and η are the Boltzmann constant, the absolute temperature
and the viscosity of the solvent, respectively.
For aggregation assays, peptide aqueous solutions of 25 μM were
added into 7.8 μM/7.8 μM DPPC/DPPG liposomes at 50 °C. After
vortexing for 30 s at 1200 rpm, the solutions were measured by laser
light scattering. The molar ratio of peptides/liposomes was deﬁned as
ρp/l.
2.6. Membrane fusion assay
Membrane fusion of liposomes was determined by the ﬂuorescence
resonant energy transfer between NBD-DPPE and Rh-DPPE [23]. NBD-
DPPE and Rh-DPPEwere incorporated into one population of liposomes
(“labeled liposomes”) at 1 mol% each, a probe concentration at which
there was signiﬁcant NBD quenching by Rh. The labeled vesicles were
thenmixedwith vesicles containing no ﬂuorescent phospholipids (“un-
labeled liposomes”) at a ratio of 1:9. The residual ﬂuorescence intensity
I0 was taken as 0% of themaximum ﬂuorescence. The total lipid concen-
tration was 15.6 μM. The peptide was then added. The measured ﬂuo-
rescence was denoted as It. Complete intermixing of all the bilayers
upon fusion would be expected to result in a membrane containing
0.1 mol% each of the two ﬂuorescent phospholipids. The liposome con-
taining 0.1 mol% of each probes, but prepared separately, was used to
calibrate the 100% maximum ﬂuorescence intensity I∞. The percentage
of fusion was calculated as F(%) = 100 × (It− I0)/(I∞ − I0).
2.7. Antimicrobial assay
Antimicrobial assays were performed with E. coli (ATCC25922),
using BrothMicrodilution protocol established by the Clinical and Labo-
ratory Standards Institute (CLSI) [24]. Stock solution of each peptide
was serially diluted at a 1/2 ratio.
E. coli was cultured for 4 h in Mueller–Hinton Broth (MHB). It was
ﬁrst adjusted to 0.5 McFarland standard in fresh broth medium, and
then diluted at 1:200. 100 μL bacteria solution and 100 μL peptide solu-
tion inMHBweremixed, added into eachwell of a 96-well plate in trip-
licate. Bacteria- and peptide-free MHB was used as a control. After an
incubation of 24 h at 37 °C, the growth of the bacteria was recorded vi-
sually. Theminimum inhibitory concentration (MIC)was determined as
the lowest concentration at which no growth occurred. Each measure-
ment was repeated for 3 times, and the average was calculated.
2.8. Cytotoxicity assay
HEK293 cells were grown in Dulbecco's modiﬁed Eagle's medium
supplemented with 10% fetal bovine serum (HyClone Laboratories,
Inc.), 100 units/mL penicillin, and 100 μg/mL streptomycin (Life Tech-
nologies, Gibco).
To evaluate the cytotoxicity of the peptides, HEK293 cells were seed-
ed in 96-well plates at ~6 × 103 cells/well one day before transfection.
After allowing them to grow overnight, the cells were treated with pep-
tides at concentrations of 64, 32, 16 and 8 μg/mL, and further incubated
for 24 h. Then, the culture medium was removed and 20 μL of CCK-8reagent (Dojindo Molecor Technologies, Inc.) was added into each
well, and incubated for 2 h under normal condition. At the end of incu-
bation, the absorbancewas read at 450 nmwith a referencewavelength
of 650 nm. The absolute absorbance (ODnet450) is OD450 minus OD650.
For comparison of relative viability, all data were presented as the
mean percentage ± SEM in pentaplicate samples compared to the ab-
sorbance value of themock-treated cells. Cell viabilitywas calculated as:
Cell viability %ð Þ ¼ ODnet450 sampleð Þ=ODnet450 mockð Þ
 
 100% ð6Þ
where ODnet450(sample) is the absorbance of the transfected cells at
450 nm and ODnet450(control) is the absorbance of the mock control
(non-transfected cells) at 450 nm.
3. Results
3.1. Secondary structures of candidate AMPs
CD measurements were performed to examine the second struc-
tures of the designed AMP peptides, in aqueous and in hydrophobic so-
lutions. In the study, pure water instead of Hepes buffer, was used as
solvent to remove noise signal of NaCl. For the same reason, 50% TFE so-
lution was used to mimic the hydrophobic environment of the mem-
brane [25]. CD spectra of the peptides in water or 50% TFE were
obtained and shown in Fig. 1. The results indicated that, while peptide
(KL2KL3)2 and K6L16K6 were mainly in an α-helix structure in water,
all the other peptides took a random structure. In 50% TFE solution, all
the peptides took an ordered secondary structure, with an exception
of K14 existing still in a random structure.
To quantitatively analyze the structures of the peptides (except K14)
in hydrophobic solution, CDpro software (SELCON3 method) [26] was
used to calculate the content of various secondary structures. As
shown in Table 1, all the 14-mer peptides composing of K and L
((KL2KL3)2, (KL2KL2K)2, K3L8K3 and K6L8) formed high content (N =
50%)α-helix in a hydrophobic environment. Comparedwith other pep-
tides, the α-helix content was relatively low for K3I8K3 (35%) and in
K6L16K6 (41%). In contrast, K3V8K3 peptide formedmainlyβ-sheet struc-
ture (34%), with α-helix content of only 10%.
To reveal the structural details of theα-helixes formed in hydropho-
bic solution, their helical wheel diagrams were drawn. As shown in
Fig. 2, the α-helix formed by (KL2KL3)2 or (KL2KL2K)2 was amphiphilic
across the diameter, where the charged residues were located on one
side and the hydrophobic residues were located on the opposite side.
The two structures differed in the ratios of the charged residues, 1/3 in
(KL2KL3)2 and 1/2 in (KL2KL2K)2. The amphiphilic featurewas presented
for the other peptides, the charged residues, however, distributed along
the axis of the helix, instead of across the diameter. As shown in Fig. 2, a
hydrophobic block located at one side of the α-helix formed by K6L8;
whereas for K3L8K3, a hydrophobic block formed in the middle of the
structure. The α-helixes formed by K3I8K3 and K6L16K6 were similar to
that of K3L8K3.
3.2. Effects on liposome leakage
To mimic the interaction between AMPs and the negatively charged
bacterial membrane, an anionic liposome composing of DPPC and DPPG
at 1/1molar ratiowas chosen as themodelmembrane. Even though it is
different from the bacterial membrane, the basic principles should
apply when studying the physical interactions between peptides and
lipids. DPPC and DPPG were completely miscible at temperatures
below or above the melting point, no phase separation occurred. The
charge content was ﬁxed at 50% to facilitate the electrostatic interaction
between liposome and peptide.
Liposome leakage assay was often used to evaluate the membrane
disruption capacity of AMPs. In our study, the leakage of liposome was
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mixing the liposome with a given peptide. Fig. 3 compares the leakage
curves of the liposome in the presence of the studied peptides. The leak-
age in Fig. 3A is slightly above 100%, which is within the experimental
error. As shown in Fig. 3, all the peptides caused evident liposome leak-
age at 50 °C. The leakage curves of all the bola-typed peptides, including
K3L8K3, K3I8K3, K3V8K3, and K6L18K6 can be ﬁtted by a double exponen-
tial growth model (Eq. 8), while the rest showed a simple exponential
rise to maximum and can be ﬁtted by Eq. 7. The characteristic(A) (KL2KL3)2 (B) (KL2K
(D) K3L8K3  (E) K 3I
Fig. 2.Helical wheel diagrams of amphiphilicα-helical peptides (KL2KL3)2 (A) and (KL2KL2K)2 (
(F).time(s) of leakage calculated by Eqs. 7 and 8, and the leakage percent-
age in 1 h, are listed in Table 2.
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:
Table 2
Experimental data with model cell and MIC.a
MIC/μM Survive fraction in MIC/% Leakage kineticsb Aggregation kineticsc Fusion kineticsb
(KL2KL2K)2 2 122 ± 12 100(12 s) 2.0(N/A) 10(N/A)
K3L8K3 9 108 ± 1 80(1.1 s/185 s)* 16(670 s) 80(380 s)
K14 9 102 ± 5 70(600 s) 20(25 s) 67(1200 s)
K3V8K3 10 97 ± 2 40(20 s/1200 s)* 11(360 s) 40(300 s)
K6L8 18 116 ± 3 83(15 s) 20(40 s) 80(0.4 s/1000 s)*
(KL2KL3)2 19 13 ± 5 100(10 s) 7.0(63 s) 60(10 s)
K3I8K3 N/A N/A 93(12 s/400 s)* 16(140 s) 80(10 s/770 s)*
K6L16K6 N/A N/A 95(10 s/1400 s)* Precipitate Precipitate
*The characteristic times are calculated by ﬁtting the curves through y ¼ y0þ A 1− exp − tτ0
  
þ B 1− exp − tτ1
  
;the others are calculated by ﬁtting the curves through y ¼ y0þ A
1− exp − tτ0
  
.
a Minimal inhibitory concentration is deﬁned as the point of nearly 100% inhibition of E. coli's growth compared with the control.
b Fusion or leakage percentage in 1 h. The numbers in the brackets show the corresponding characteristic time.
c Final aggregation number. The characteristic aggregation time is shown in the brackets.
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2990 J. Sun et al. / Biochimica et Biophysica Acta 1838 (2014) 2985–2993The leakage was very fast in some cases. Since the initial value was
known, the ﬁtting still yielded valid kinetic data for comparison. As
shown in Table 2, all the 14-mer peptides containing both K and L re-
sulted in faster leakage rates and higher leakage content in 1 h. Replac-
ing L by I or V compromised the leakage by either decreasing the
kinetics (K3I8K3) or lowering the leakage percentage (K3V8K3). In the
case of K3V8K3, the leakage content in 1 h was only 40%, much lower
than those of the others. K14 contains no hydrophobic residues. Its leak-
age rate was the slowest among the tested peptides. The leakage of the
liposome in the presence of the bola-typed peptides can be described by
a function of double exponential growth (Eq. 8), and the rate at each
stage followed the order of K3L8K3 b K3I8K3 b K3V8K3, suggesting that
the bola-typed peptides disrupted the membrane in two steps, and
the degree of hydrophobicity was important at each step. Taken togeth-
er, these data indicated that the hydrophobic residues played a key role
in disrupting the membrane.3.3. Antimicrobial activity
Antibacterial activity of the peptides were tested with E. coli. A MIC
value was determined for each peptide, using Broth microdilution pro-
tocol [19,27]. Melittin, a natural antimicrobial peptide, was included in
the assays as a reference. While no antibacterial activity was observed
for K3I8K3 and K6L16K6 at concentrations of 1.0–64 μg/mL, the activity
of the other six peptides were presented in Fig. 4. From which, a MIC(A): (KL2KL2K)2
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Fig. 4.Antimicrobial activities of candidate AMPs: (A) (KL2KL2K)2, (B)K3L8K3, (C) K6L8, (D) K3V8K
Blocks 1 and 2 in each panel show the activities on E. coli and HEK293 cells, respectively.value was obtained for each peptide and summarized in Table 2. Ac-
cording to the MICs, the peptides were divided into three groups.
Group 1 contains (KL2KL2K)2 only, whose MIC value (2 μM or
8 μg/mL) is the lowest among the tested peptides including melittin
(3 μM) (Fig. S1). Group 2 contains K14, K3V8K3, K3L8K3, K6L8, and
(KL2KL3)2, whose MIC values range from 9 to 18 μM (16–32 μg/mL).
Group 3 contains K3I8K3 and K6L16K6. Interestingly, no antibacterial ac-
tivity was observed for this group (Fig. S1).
To evaluate their cytotoxicities, CCK-8 assays were performed with
cultured HEK293 cells, at concentrations around the identiﬁed MIC.
The results were presented in Block 2 of each panel in Fig. 4, and sum-
marized in Table 2. It was found that, with the exception of (KL2KL3)2,,
all the peptides were safe to normal cells at the MIC doses.
The data in Table 2 revealed a non-proportional correlation between
liposome leakage and antibacterial activity. For example, around MIC
concentration, K3I8K3 caused an extensive liposome leakage, however,
no antibacterial activity was observed. Both K14 and K3V8K3 were
weak in membrane disrupting as demonstrated by the long leakage
characteristic time or low leakage content within 1 h. However, their
MIC values were relatively low.3.4. Effects on liposome aggregation and membrane fusion
To further characterize the behavior of the peptides, two other index
assays, liposome aggregation and membrane fusion, were carried out.(B): K3L8K3
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leakage in most cases, occurring earlier or at the same time [18,28].
The kinetics of liposome aggregation and membrane fusion was moni-
tored using time-resolved laser light scattering (LLS) and FRET. The ex-
periment settings were the same as those of liposome leakage assay.
The results showed that all the peptides caused liposome aggregation
with varying kinetics. The degree of the aggregations was also different,
as quantitatively measured by the aggregation number. Since the
scattered intensity I is proportional to the molecular weightM at ﬁxed
concentration [29], the aggregation number M/M0 can be estimated
using I/I0, with I0 and I being the excess scattered intensity of the lipo-
some before and after the addition of peptide.
Fig. 5A compares the LLS data of (KL2KL2K)2, K6L8, and K3L8K3. LLS
data of the other peptides were shown in Fig. S2. Except for (KL2KL2K)
2 and K6L18K6, Similar aggregation curves were observed for the other
peptides. An overshoot curve was observed for (KL2KL2K)2 at the very
beginning of the assays; while for K6L18K6, extensive precipitation oc-
curred in the assays. Monomodal distributions were observed during
the aggregation process (Fig. 5C). The aggregate size and the distribu-
tion varied over the course, depending on the type of the peptides
(Fig. 5B). Fitting the aggregation curves by Eq. 7 or Eq. 8 yielded a char-
acteristic time for most of the peptides. These values, together with the
aggregation numbers after reaching equilibrium, are shown in Table 2.
The lowest aggregation number was found with (KL2KL2K)2, followed
by (KL2KL3)2, andK3V8K3. The other peptides resulted in heavy aggrega-
tion of the liposomes, even led to macrophase separation in the case of
K6L18K6.
Using a similar approach, the kinetics of membrane fusion was de-
termined for each peptide. Fig. 5D compares the membrane fusion me-
diated by (KL2KL2K)2, K6L8, and K3L8K3. Similar fusion curves were
observed for the other peptides except K6L16K6, which led to a heavy
precipitation (Fig. S3). The characteristic time and the fusion percentage
in 1 h are listed in Table 2. The fastest fusion occurred in the presence of
(KL2KL3)2, K6L8, and K3I8K3, while K14 showed the slowest fusion(A)
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tration is 25 μM; c(DPPC/DPPG) = 15.6 μM; ρp/l = 0.053. The dashed curves in Panels A and Dprocess probably owing to the lack of hydrophobic residues. The degree
of fusionwas the lowest for (KL2KL2K)2, only about 10%. K3V8K3 also led
to low level (40%) of membrane fusion.
4. Discussion
A comprehensive data set including the antibacterial activity, the ki-
netics of membrane leakage, aggregation and fusion, was presented in
Table 2. Correlation analysis found that neither the liposome leakage
nor the content of α-helix structure could serve as a sole criterion to
predict the antimicrobial activity of the peptides. For example, neither
K14 nor K3V8K3 formedprominentα-helix conformation in hydrophobic
environment, they however exhibited moderate antimicrobial activi-
ties. In the cases of K3I8K3 and K6L16K6, a nearly 100% liposome leakages
weremediated in 1 h; however, no antimicrobial activitywas identiﬁed.
Among the tested peptides, (KL2KL2K)2 showed the best perfor-
mance. Its MIC value was 2 μM, a value comparable to that of melittin
[30], and much lower than the other peptides. The major difference be-
tween (KL2KL2K)2 and the other peptides was that it induced negligible
liposome aggregation and membrane fusion while mediating heavy
membrane leakage. From a view of physics, liposome aggregation, fu-
sion, and leakage followed distinct mechanisms. The aggregation was
driven mainly by inter-particle attraction, for example electrostatic in-
teraction. It was a strong and long-ranged interaction, effective in
pulling the oppositely charged particles together. This was demonstrat-
ed by the fast and efﬁcient aggregation in the presence of K14. The fusion
ofmembrane depends not only on the inter-particle attraction force, but
also on the merging of the outer leaﬂet of the membrane, which in-
volves hydrophobic interactions. Therefore, liposome aggregation was
a prerequisite for fusion. As shown in Table 2, obvious fusion could
not occur without aggregation. In contrast, liposome leakage, which re-
sulted from the disruption of the membrane, was closely related to the
antimicrobial activity. The pore-formingmechanism,where the interac-
tion mainly was located inside the membrane, was believed to be the(B)
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and “toroidal-pore” are the most common models used to describe the
membrane disruption mechanism [31]. In all these models, the leakage
was more efﬁcient if the peptides were able to insert inside the mem-
brane instead of working in between membranes to cause aggregation
or fusion [32,33]. Therefore, the aggregation and the fusion, which did
not necessarily generate leakage, alleviated the antimicrobial activity
bydiversifying the functions of AMPs. (KL2KL2K)2 in Table 2met this cri-
terion. An overshoot in aggregation was thus observed when the inter-
action location shifts from inter-particle (aggregation) to intra-particle
(leakage) (Fig. 5A). The behaviors of K6L8 and K3L8K3 also proved this
viewpoint. Their chemical composition and chain length are the same
as those of (KL2KL2K)2, but their antimicrobial activities were much
lower. This is likely due to their capability to induce efﬁcientmembrane
aggregation or fusion. Another example was (KL2KL3)2. Both (KL2KL3)2
and (KL2KL2K)2 formed amphiphilic α-helix structure. The only differ-
ence was that the former had a larger hydrophobicity/charge ratio.
However, the antimicrobial efﬁciency of (KL2KL3)2 was signiﬁcantly
reduced. This can be attributed to the non-speciﬁcity of (KL2KL3)2 in
causing membrane leakage, since relatively strong aggregation and
fusion were also observed in the presence of (KL2KL3)2 at the same
conditions.
Table 2 also shows that (KL2KL3)2 exhibited much strong activity in
killing normal cells, in agreement with that higher hydrophobicity de-
creases cell-selectivity [3–5]. Unlike bacteriamembrane, cell membrane
contains negligible amount of negative charges [31]. The hydrophobic
interaction was thus more important than electrostatic interaction
when peptide interacts with cell membrane. Assuming leucines formed
regular α-helix, the hydrophobic length of 8 connecting leucines was
about 1.2 nm (0.15 nm × 8) [34], which was smaller than half of the
thickness of cell membrane (the thickness of lipid bilayer is ~3.0 nm).
Therefore, the cells were safe for that most of the 14-mer peptides
shown in Table 2 cannot penetrate and disrupt the cell membrane.
(KL2KL3)2 was an exception. It formed an α-helix of 2.1 nm (more
than half of the membrane thickness) and highly hydrophobic, signiﬁ-
cantly enhanced its power in destroying cell membranes. Although
(KL2KL2K)2 had the same length as (KL2KL3)2, its lower hydrophobicity
might compromise its ability in disrupting cell membrane. Therefore,
both the hydrophobicity/charge ratio and the depth of the peptide in-
side the membrane were involved in the selectivity. The hydrophobici-
ty/charge ratio should have an optimal value or value range, while the
interaction depth, as indicated in our work, was related to the hydro-
phobicity of the peptide, and was likely in between half to 2/3 of the
cell membrane.
It was not clear why K3I8K3 and K6L16K6 mediated no antimicrobial
activities. K6L16K6 had a strong tendency to self-aggregate in aqueous
solution, leading to a heavy precipitation when contacting with lipo-
some. As for K3I8K3, the α-helix content (Table 1) was much lower
than that of K3L8K3. Other undeﬁned reasonsmight explain the compro-
mised membrane disruption activity of isoleucine.5. Conclusion
In this study, a series of candidate AMPs composing of two amino
acids (lysine and leucine in most cases) were designed and tested, in
termsof antimicrobial activity,membrane aggregation, fusion, and leak-
age. No evident correlationwas identiﬁed between the antimicrobial ac-
tivity and the property of the peptides such as the sequence, length,
hydrophobicity/charge ratio and secondary structure. However, com-
mon activities againstmodelmembranewere nevertheless found corre-
lated with the antimicrobial activity, in that mediating efﬁcient
membrane leakage, negligible membrane fusion and liposome aggrega-
tion. These results indicated that when a peptide could mediate an efﬁ-
cient intramembrane interaction, it also leads to higher inhibition on
bacteria growth.Acknowledgement
This work was supported by the National Natural Science Founda-
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